NCT06683352 — Influenza,Human trial site landscape

Public-registry site landscape for NCT06683352, “A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People”, a Influenza,Human study sponsored by BioNTech SE. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT06683352 (registry record)
Study title	A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
Official title	A PHASE 1/2, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF COMBINED VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
Sponsor	BioNTech SE
Condition(s)	Influenza,Human; COVID-19
Phase	PHASE1 / PHASE2
Listed sites	22
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT06683352.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT06683352 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →